Three Primary Cancers in a Veteran With Agent Orange and Agent Blue ExposuresAugust 18, 2021OncologyMixed TopicsGenitourinary Cancer
‘Routine’ use of focal therapy for prostate cancer in next 5 yearsAugust 11, 2021Genitourinary CancerOncology
Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerOncology
The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration(FULL)August 2, 2021OncologyProstate Cancer
Integrating Germline Genetics Into Precision Oncology Practice in the Veterans Health Administration: Challenges and Opportunities (FULL)August 2, 2021Oncology
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision Oncology(FULL)August 2, 2021Oncology
Prostate Cancer Foundation-Department of Veterans Affairs Partnership: A Model of Public-Private Collaboration to Advance Treatment and Care of Invasive Cancers(FULL)August 2, 2021Oncology
New investigational helmet device shrinks glioblastomaJuly 30, 2021Head & Neck/Thyroid CancersOncology
